SCHEMBL7238236

SCHEMBL7238236

CCCCOC(=O)N(C(=O)OCCCC)c1ncnc(N)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
PKM P14618 1/20 0.51
ALDH1A1 P00352 4/20 0.39
TSHR P16473 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2C9 P11712 1/20 0.39
PDE4D Q08499 1/20 0.39
HSD17B10 Q99714 2/20 0.38
L3MBTL1 Q9Y468 4/20 0.36
AHCY P23526 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MAPT P10636 2/20 0.35
CYP2D6 P10635 2/20 0.35
HSP90AA1 P07900 1/20 0.35
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15263572 0.81 L3MBTL1 (0.43) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL7243752 0.81 RAB9A (0.40) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL7237370 0.78 SMN1; SMN2 (0.45) LMNASMN1; SMN2PKMALDH1A1NPC1
SCHEMBL7244191 0.76 RAB9A (0.45) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL6270005 0.73 RAB9A (0.51) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL15263575 0.69 LMNA (0.38) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL4422288 0.69 LMNA (0.38) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2
SCHEMBL10785114 0.67 LMNA (0.45) LMNASMN1; SMN2PKMCYP1A2CYP2C19
SCHEMBL18117673 0.67 MAPT (0.60) LMNASMN1; SMN2PKMALDH1A1TSHR
SCHEMBL22502724 0.67 NPC1 (0.41) LMNASMN1; SMN2ALDH1A1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506898-B1 Halogen-free, purity; curing agents CYTEC TECHNOLOGY CORP. 2003-01-14 US disclosed
EP-0624577-B1 Process for the preparation of 1,3,5-triazine carbamates, at least biscarbamate functional 1,3,5-triazines CYTEC TECH CORP (US) 2001-09-19 EP disclosed
US-6288226-B1 CURING CARBONATES CYTEC TECHNOLOGY CORPORATION 2001-09-11 US disclosed
US-6063922-A Carbamate functional 1,3,5-triazines CYTEC TECHNOLOGY CORP. (US) 2000-05-16 US disclosed
EP-0976739-A2 A Process for the preparation of 1,3,5-triazine carbamates, at least biscarbimate functional 1,3,5-triazines as well as use of 1,3,5-triazine carbamates CYTEC TECHNOLOGY CORP. (US) 2000-02-02 EP disclosed
US-5792866-A Process for the preparation of 1,3,5-triazine carbamates from amino 1,3,5-triazines and organic carbonates CYTEC TECHNOLOGY CORPORATION (US) 1998-08-11 US disclosed
US-5705641-A Process for the preparation of 1,3,5-triazine carbamates from amino-1,3,5-triazines and organic carbonates CYTEC TECHNOLOGY CORP. (US) 1998-01-06 US disclosed
EP-0624577-A1 Process for the preparation of 1,3,5-triazine carbamates, at least biscarbamate functional 1,3,5-triazines and their use as crosslinkers CYTEC TECHNOLOGY CORP. (US) 1994-11-17 EP disclosed